Thrilled w/ $ENZC's filing Aug. 25, 2022 of its International Publication for its Patent "for conserved antigens and epitopes of SARS-CoV-2"!!! ~ WOO-HOO!!!
But what I don't understand is WHY hasn't this been announced in Accesswire, just as its International Publication of its Patent for HIV-AIDS was in July 28th PR.
WHAT's the difference between the significance of Enzolytics' Aug. 25th Filing of its International Publication re. its COVID mAbs, and Enzolytics' July 28th Accesswire PR Announcing its HIV/AIDS mAbs: "The International Patent Office Search Report finding Novelty and Inventiveness in the Company's Pending International Patent Application Covering its anti-HIV Monoclonal Antibodies"?
THANKS TO ANYBODY who would care to venture an explanation of this difference!